Semler Scientific Inc (SMLR) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Semler Scientific inc   (NASDAQ: SMLR)


Semler Scientific Inc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Semler Scientific Inc's ROI in the third quarter of 2025?
Semler Scientific inc achieved a return on average invested assets (ROI) of 12.68 % in its third quarter of 2025, which is below Semler Scientific Inc's average return on investment, which stands at 199.33%.

ROI decreased relative to the period ending Jun 30 2025, due to the decline in net income.

Within the Healthcare sector 84 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from 506 to 599.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Investment Change TTM 386.31 % 252.51 % 128.28 % 75.6 % 23.94 %
Y / Y Net Income Change TTM 203.75 % 134.19 % - 320.12 % 188.61 %
Investment (TTM) in Millions 556 480 258 231 85
Return On Investment (TTM) 12.68 % 14.07 % -18.32 % 34.63 % 20.31 %
SMLR's Overall Ranking # 599 # 506 # 3412 # 155 # 324
Seq. Investment Change TTM 44.69 % 61.52 % 38.08 % 50.71 % 4.88 %
Seq. Net Income Change TTM 30.48 % - - 157 % 0.6 %
Net Income (TTM) in Millions 48 37 -30 41 16

SMLR Company Profile >> Back to SMLR Roi Comparisons >> See Annual SMLR Return On Investment



Return On Investment SMLR's Ranking
Within: No.
Industry # 18
Sector # 85
Overall # 599

Return On Investment Statistics
High Average Low
9637.27 %
199.33 %
-2095.3 %
(Sep 30 2018)   (Mar 31 2016)







Financial Statements
Semler Scientific Inc's III. Quarter Investments $ 556 Millions SMLR's Balance sheet
Semler Scientific Inc's III. Quarter Income $ 17 Millions Quarterly SMLR's Income Statement
SMLR's Income by Division See SMLR's Income by Division


SMLR Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 231 72 56 46 30
Y / Y Investment Growth 221.4 % 28.95 % 21.58 % 52.01 % 130.31 %
Net Income in Millions 41 21 14 17 14
Y / Y Net Income Growth 98.7 % 43.69 % -16.82 % 22.95 % -7.14 %
Annual Return On Investment 17.72 % 28.67 % 25.73 % 37.61 % 46.5 %


Annual Roi Comment
In the fiscal year 2024 ROI deteriorated to 17.72 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SMLR's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SMLR's Competitors
Subscribers only: Roi for Semler Scientific Inc's Suppliers
Subscribers only: Return On Investment for SMLR's Customers

Other Ratios
SMLR's Roa SMLR's Inventory Turnover Ratio SMLR's Growth Rates SMLR's Dividend Statistics
SMLR's Profitability Ratios SMLR's Asset Turnover Ratio SMLR's Dividend Growth
SMLR's Roe SMLR's Valuation Ratios SMLR's Financial Strength Ratios SMLR's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI
Siga Technologies Inc  33.53 %
Cytomx Therapeutics Inc   33.34 %
Sbc Medical Group Holdings Incorporated  33.23 %
Halozyme Therapeutics Inc   32.75 %
Medpace Holdings Inc   31.78 %
Puma Biotechnology Inc   31.53 %
Eli Lilly And Company  31.20 %
Synlogic Inc   31.15 %
Acadia Pharmaceuticals Inc   29.91 %
Sab Biotherapeutics Inc   29.19 %
Incyte Corporation  27.38 %
Oramed Pharmaceuticals Inc  27.03 %
Longduoduo Co Ltd  26.30 %
Catalyst Pharmaceuticals Inc   26.29 %
Carlisle Companies Incorporated  25.18 %
Rafael Holdings Inc  24.36 %
Lifevantage Corp  23.83 %
Zoetis Inc   22.27 %
Merck and Co Inc   22.18 %
Iradimed Corporation  22.15 %
Indivior Pharmaceuticals Inc   21.95 %
Pro dex Inc   21.53 %
Resmed Inc   20.55 %
Abbott Laboratories  19.55 %
Exagen Inc   19.38 %
Alkermes Plc   19.28 %
Krystal Biotech Inc   19.18 %
Illumina Inc   18.91 %
Vertex Pharmaceuticals Inc  18.76 %
Dexcom Inc   18.66 %

Date modified: 2026-09-08T22:21:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.